Test Price
1,800 AED✅ Home Collection Available
Duchenne / Becker Muscular Dystrophy (DMD / BMD) Gene Mutation Test in UAE | 1800 AED | 2026 DHA Guidelines
تحليل طفرة جين دوشين / بيكر لضمور العضلات في الإمارات | 1800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary & UAE Patient Guarantee
- Diagnostic Precision: 99.9% analytical sensitivity and specificity via MLPA technology, processed in an ISO 9001:2015 accredited facility (Cert: INT/EGQ/2509DA/3139).
- Premium Home Collection: VIP mobile phlebotomy with validated cold‑chain logistics (8 AM – 11 PM daily). No clinic visit required.
- Clinical Guidance: Post‑test telephonic interpretation session with a DHA‑licensed neurologist to explain your child’s or your results in context.
- Insurance & Billing: Direct insurance verification and pre‑approval via WhatsApp (+971 54 548 8731) – we handle the paperwork.
الملخص التنفيذي المعتمد من هيئة الصحة
فحص طفرة دوشين/بيكر بتقنية MLPA المتطورة يضمن دقة تصل إلى 99.9%، مع خدمة جمع العينات منزلياً وفق معايير التبريد العالمية ودعم سريري فوري بعد النتائج. جميع التحاليل معتمدة من هيئة الصحة بدبي وموافقة لقانون المسؤولية الطبية الاتحادي رقم 41 لسنة 2024.
Overview: DMD/BMD Gene Mutation Analysis
The Duchenne / Becker Muscular Dystrophy (DMD/BMD) gene mutation test detects deletions and duplications in the dystrophin gene using Multiplex Ligation‑dependent Probe Amplification (MLPA) — the gold‑standard first‑tier assay endorsed by 2026 DHA neuromuscular guidelines. This blood‑based test identifies the genetic cause in approximately 70‑80% of affected males, guiding precise diagnosis, carrier screening, and future therapeutic eligibility.
يكشف تحليل طفرة جين الديستروفين عن الحذف أو التضاعف المسؤول عن ضمور العضلات من النوعين دوشين وبيكر، وهو الفحص الأساسي المعتمد من هيئة الصحة بدبي للتشخيص الدقيق والاستشارة الوراثية.
| Feature | Our DHA‑Approved Test | Closest Alternative (Generic Lab) |
|---|---|---|
| Methodology | MLPA (Multiplex Ligation‑dependent Probe Amplification) – full deletion/duplication coverage of all 79 exons | MLPA or limited NGS panel, no DHA‑specific pre‑analytic validation |
| Diagnostic Sensitivity | 99.9% analytical specificity; includes reflex confirmatory analysis if needed | Often 95-98% without internal quality cross‑checks |
| Turnaround Time | 3 weeks (21 calendar days) from sample arrival | 4‑6 weeks |
| Price (AED) | 1,800 AED – inclusive of home collection, clinical summary, and insurance handling | 2,000‑2,500 AED (hidden fees for forms/reports) |
| UAE Regulatory Compliance | Full compliance with Federal Decree‑Law No. 41 of 2024 (Art. 87), UAE PDPL genomic data privacy, and CDS Law 2026 for minors | Often missing documented UAE genetic consent and pediatric protection protocols |
| Post‑Test Support | Free telephonic clinical guidance with a DHA‑licensed neurologist | Result only; no genetic counselling included |
Clinical Correlation & Safety Protocol
DR A Note from Dr. Prabhakar Reddy, DHA‑Licensed Neurologist (DHA: 61713011)
“This MLPA test reliably identifies large deletions and duplications that account for the majority of Duchenne and Becker muscular dystrophy cases; however, a normal result does not exclude point mutations or rare deep intronic variants. I strongly recommend that every result be interpreted in the context of a complete neuromuscular examination, creatine kinase levels, and family history. Please remember that a genetic diagnosis is a powerful step — it opens the door to anticipatory care, clinical trials, and family planning, but it must be integrated thoughtfully into your child’s overall healthcare journey.”
⚠️ Medication Notice
Do not discontinue or adjust any prescribed medication (e.g., corticosteroids, cardiac medications) without explicit instruction from your treating physician. Abrupt medication changes may precipitate life‑threatening complications in muscular dystrophy.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion criteria: Acute febrile illness, blood transfusion within the last 4 weeks, or active systemic infection. Home phlebotomists are trained to defer collection if unsafe.
- Pediatric/minor consent: In strict accordance with UAE CDS Law 2026, a parent or legal guardian must provide written consent and complete Form 20.
- Red flags requiring ER evaluation (not this test): Sudden loss of ambulation, severe respiratory distress, choking, cardiac arrhythmia, or loss of consciousness. This genetic test does not address acute neuromuscular emergencies.
- Data privacy: Your genomic data is protected under UAE PDPL and stored exclusively on DHA‑compliant encrypted servers. It will never be shared without your written authorization.
Patient FAQ & Clinical Guidance
Q1: Is fasting required for the Duchenne/Becker gene mutation blood test?
Snippet Answer: Fasting is absolutely not required; however, a completely filled Genomics Clinical Information Requisition Form (Form 20) is mandatory for sample acceptance. The blood draw can be performed any time of day, and normal eating and drinking do not affect the DNA analysis.
لا يتطلب فحص طفرة جين دوشين أي صيام، ولكن يجب إتمام استمارة المعلومات السريرية للجينوم (النموذج 20) بشكل كامل كشرط إلزامي لقبول العينة. يمكن سحب الدم في أي وقت خلال اليوم، ولا يؤثر الأكل والشرب الطبيعي على تحليل الحمض النووي.
Q2: How long do DMD/BMD mutation results take, and how will I receive them?
Snippet Answer: Results are finalized within 21 calendar days (3 weeks) from the day the sample reaches our ISO‑accredited laboratory. A secure, encrypted PDF report is sent via email, and a DHA‑licensed neurologist schedules a phone consultation to explain the findings, answer questions, and recommend next steps at no extra cost.
تظهر النتائج النهائية خلال 21 يومًا تقويميًا (3 أسابيع) من وصول العينة إلى مختبرنا المعتمد. يتم إرسال تقرير مشفر بصيغة PDF عبر البريد الإلكتروني، ثم يقوم طبيب أعصاب مرخص من هيئة الصحة بدبي بالاتصال هاتفياً لشرح النتائج وتقديم التوصيات الطبية دون أي تكلفة إضافية.
Q3: Will my health insurance cover the DMD/BMD genetic test, and how do I check?
Snippet Answer: Most UAE insurance plans cover this medically necessary genetic when a physician referral and completed Form 20 are provided. Simply send your insurance card and Emirates ID via WhatsApp to +971 54 548 8731, and our team will verify direct billing eligibility within 2 hours, saving you upfront payment.
تغطي معظم خطط التأمين الصحي في الإمارات هذا الفحص الجيني الضروري طبياً عند توفر إحالة طبيب واستمارة رقم 20. أرسل بطاقة التأمين والهوية الإماراتية عبر واتساب إلى +971 54 548 8731، وسنتحقق من أهلية الدفع المباشر في غضون ساعتين.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians